4.30
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABCL Giù?
Forum
Previsione
Abcellera Biologics Inc Azioni (ABCL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
303.40%
17.08
|
4.235 | 6.507 | 7.323 | 9.954 |
|
0.34%
66.67
|
66.89 | 100.17 | 100.78 | 64.85 |
Benefits Costs and Expenses |
6.63%
53.43
|
57.22 | 69.14 | 55.51 | 52.70 |
Costs And Expenses |
6.63%
53.43
|
57.22 | 69.14 | 55.51 | 52.70 |
Depreciation and Amortization |
2.61%
5.47
|
5.331 | - | - | 4.844 |
Operating Income/Loss |
20.87%
-49.59
|
-62.66 | -93.66 | -93.45 | -54.89 |
Nonoperating Income/Loss |
36.84%
13.24
|
9.676 | 31.03 | 45.27 | 12.15 |
Income/Loss From Continuing Operations Before Tax |
31.41%
-36.34
|
-52.98 | -62.63 | -48.19 | -42.75 |
Income Tax Expense/Benefit |
78.04%
-1.617
|
-7.363 | -11.53 | -11.26 | -2.137 |
Income/Loss From Continuing Operations After Tax |
23.88%
-34.73
|
-45.62 | -51.11 | -36.93 | -40.61 |
|
23.88%
-34.73
|
-45.62 | -51.11 | -36.93 | -40.61 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.27%
298.51
|
297.69 | 294.85 | 294.22 | 292.72 |
Diluted Average Shares |
0.27%
298.51
|
297.69 | 294.85 | 294.22 | 292.72 |
Basic Earnings Per Share |
20.00%
-0.12
|
-0.15 | -0.17 | -0.13 | -0.14 |
Diluted Earnings Per Share |
20.00%
-0.12
|
-0.15 | -0.17 | -0.13 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):